Key facts
- It has raised $31.9M; the latest was Later Stage VC in May 2024.
- Notable investors include European Union, INNVIERTE SICC, CDTI Innvierte, Caixa Capital Risc, BAMCAP — 14 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 14 names
- ·Watchlist + deal alerts for Nuubo
- ·The full record, as it builds
Funding rounds
No funding rounds for Nuubo are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Nuubo
Developer of a cardiac monitoring device designed to provide a new perspective on remote and wireless cardiological monitoring. The company's device captures electrocardiograms in dynamic environments in a continuous and non-invasive way through an innovative system based on new-generation biomedical textiles, enabling patients to monitor heart rates that are easy to use and can be worn even while outdoors.
- Sector
- Healthcare
- HQ
- Madrid, Spain
- Founded
- 2005
- Employees
- 31
- Website
- nuubo.com/
- Ownership
- Privately Held (backing)
Nuubo doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Nuubo shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Nuubo in its N-PORT filings yet. We sweep new filings monthly.